Your session is about to expire
← Back to Search
Combined Constraint Therapy + Bimanual Therapy for Hemiplegia
N/A
Waitlist Available
Research Sponsored by Blythedale Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 of intervention and day 180 of intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether it is more effective to train one hand at a time or both hands together when rehabilitating children who have suffered a brain injury on one side.
Eligible Conditions
- Hemiplegic Shoulder Subluxation
- Cerebral Palsy
- Hemiplegia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 of intervention and day 180 of intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 of intervention and day 180 of intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Assisting Hand Assessment after therapy
Secondary study objectives
Change in Assisting Hand Assessment after each three-week block of therapy
Change in Assisting Hand Assessment after therapy follow-up
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Constraint Therapy and Bimanual TherapyExperimental Treatment2 Interventions
Children in this arm will receive 90 hours (6 hrs/day, 5 days/week, 3 weeks) of Intensive Hand Therapy (constraint therapy), followed by 90 hours (6 hrs/day, 5 days/week, 3 weeks) of Intensive Bimanual Hand Therapy (bimanual therapy). During constraint therapy, children will wear a mitt over their less-impaired hand and actively use their more-impaired hand in therapy. Therapy will involve playing games, practicing activities of daily living, doing arts and crafts, and practicing repetitive hand movements. During bimanual therapy, children will actively use both hand in therapy. Therapy will involve playing games, practicing activities of daily living, doing arts and crafts, and practicing repetitive hand movements.
Group II: Bimanual Therapy and Constraint TherapyExperimental Treatment2 Interventions
Children in this arm will receive 90 hours (6 hrs/day, 5 days/week, 3 weeks) of Intensive Bimanual Hand Therapy (bimanual therapy), followed by 90 hours (6 hrs/day, 5 days/week, 3 weeks) of Intensive Hand Therapy (constraint therapy). During bimanual therapy, children will actively use both hand in therapy. Therapy will involve playing games, practicing activities of daily living, doing arts and crafts, and practicing repetitive hand movements. During constraint therapy, children will wear a mitt over their less-impaired hand and actively use their more-impaired hand in therapy. Therapy will involve playing games, practicing activities of daily living, doing arts and crafts, and practicing repetitive hand movements.
Find a Location
Who is running the clinical trial?
Blythedale Children's HospitalLead Sponsor
5 Previous Clinical Trials
147 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have vision problems that have not been fixed with glasses or contacts.You have been diagnosed with hemiplegia.You can move your wrist at least 10 degrees.The child has experience attending programs during the day without their main caregiver, like school or daycare.
Research Study Groups:
This trial has the following groups:- Group 1: Bimanual Therapy and Constraint Therapy
- Group 2: Constraint Therapy and Bimanual Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.